US Patent 8563614 Use of treprostinil to treat neuropathic diabetic foot ulcers
Patent 8563614 was granted and assigned to United Therapeutics on October, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Nov, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08563614 Use of treprostinil to treat neuropathic diabetic foot ulcers US Patent 8563614 Use of treprostinil to treat neuropathic diabetic foot ulcers
Infobox
Patent Number
0856361400
Patent Number
856361400
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
085636140
Date of Patent
October 22, 2013
0Patent Application Number
129269450
Date Filed
December 20, 2010
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
0
Patent Jurisdiction
Patent Number
085636140
Date of Patent
October 22, 2013
0Patent Application Number
129269450
Date Filed
December 20, 2010
0Patent Primary Examiner
Edits on 18 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08563614 Use of treprostinil to treat neuropathic diabetic foot ulcers
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08563614
Date of patent
October 22, 2013
Patent application number
12926945
Date Filed
December 20, 2010
Patent primary examiner
Find more entities like US Patent 8563614 Use of treprostinil to treat neuropathic diabetic foot ulcers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
